Clinical Trials

Phase I — Benign Prostatic Hyperplasia (BPH)

The purpose of this study is to evaluate the safety and effectiveness of using the Litx™ BPH System in patients with LUTS due to benign prostatic hyperplasia (BPH).

For more information about this trial, please visit the trial registration page at ClinicalTrials.gov:

Go to ClinicalTrials.gov, Trial ID # NCT00709488